2772-7246

Drug and Alcohol Dependence Reports

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 446 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact446 DOIs
2

Attach ORCID iDs across 183 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact183 DOIs
3

Deposit reference lists for 9 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact9 DOIs

DOIs for this ISSN

Showing the top 5 of 446 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Prevalence of and trends in current cannabis use among US yo… (10.1016/j.dadr.2024.100253)
Abstract ORCID
94.32 76
2 A scoping review of barriers and facilitators to the integra… (10.1016/j.dadr.2023.100152)
Abstract ORCID
76.57 33
3 Population-based examination of substance use disorders and… (10.1016/j.dadr.2023.100181)
Abstract ORCID
73.12 28
4 Fentanyl, carfentanil and other fentanyl analogues in Canada… (10.1016/j.dadr.2024.100240)
Abstract ORCID
71.57 26
5 Pilot findings on the real-world performance of xylazine tes… (10.1016/j.dadr.2024.100241)
Abstract ORCID
69.90 24
6 Substance Use Outcomes For Sexual and Gender Minority Adults… (10.1016/j.dadr.2022.100129)
Abstract ORCID
66.11 20
7 Prevalence of cannabidiol use and correlates in U.S. adults (10.1016/j.dadr.2024.100289)
Abstract ORCID
65.05 19
8 Group-based medical mistrust and care expectations among bla… (10.1016/j.dadr.2022.100026)
Abstract ORCID
63.94 18
9 Preferences, use, and perceived access to flavored e-cigaret… (10.1016/j.dadr.2022.100068)
Abstract ORCID
63.94 18
10 Substance use stigma: A systematic review of measures and th… (10.1016/j.dadr.2024.100237)
Abstract ORCID
63.94 18
11 Association of substance use with suicide mortality: An upda… (10.1016/j.dadr.2024.100310)
Abstract ORCID
63.94 18
12 Trends in emergency department visits related to acute alcoh… (10.1016/j.dadr.2022.100049)
Abstract ORCID
62.76 17
13 Sex-specific and generational effects of alcohol and tobacco… (10.1016/j.dadr.2022.100077)
Abstract ORCID
62.76 17
14 Xylazine awareness, desire, use and exposure: Preliminary fi… (10.1016/j.dadr.2024.100247)
Abstract ORCID
61.52 16
15 Treatment of post-traumatic stress disorder and substance us… (10.1016/j.dadr.2022.100028)
Abstract ORCID
60.21 15
16 Parenting and childcare responsibilities, harm reduction ser… (10.1016/j.dadr.2022.100054)
Abstract ORCID
60.21 15
17 Opioid treatment program prescribing of methadone with commu… (10.1016/j.dadr.2022.100067)
Abstract ORCID
60.21 15
18 Crisis Intervention Team (CIT) training and impact on mental… (10.1016/j.dadr.2022.100099)
Abstract ORCID
60.21 15
19 Benzodiazepine use for anxiety disorders is associated with… (10.1016/j.dadr.2024.100270)
Abstract ORCID
60.21 15
20 Prevalence of xylazine among people who inject drugs seeking… (10.1016/j.dadr.2023.100209)
Abstract ORCID
58.80 14
21 Psychostimulant drug co-ingestion in non-fatal opioid overdo… (10.1016/j.dadr.2024.100223)
Abstract ORCID
58.80 14
22 Mental health service use in a national sample of college st… (10.1016/j.dadr.2022.100025)
Abstract ORCID
57.31 13
23 The opioid epidemic among the Latino population in Californi… (10.1016/j.dadr.2022.100029)
Abstract ORCID
57.31 13
24 Implementation opportunities for scaling up methadone mainte… (10.1016/j.dadr.2022.100075)
Abstract ORCID
57.31 13
25 Under-representation of key demographic groups in opioid use… (10.1016/j.dadr.2022.100084)
Abstract ORCID
57.31 13
26 What is the prevalence of and trend in opioid use disorder i… (10.1016/j.dadr.2022.100052)
Abstract
56.62 183
27 Changes in dependence over one year among US adults who smok… (10.1016/j.dadr.2023.100137)
Abstract ORCID
55.70 12
28 The substance use disorder treatment gap among US college st… (10.1016/j.dadr.2024.100279)
Abstract ORCID
55.70 12
29 Stressors experienced during the COVID-19 pandemic and subst… (10.1016/j.dadr.2021.100005)
Abstract ORCID
53.96 11
30 Disparities in opioid treatment access and retention among w… (10.1016/j.dadr.2022.100030)
Abstract ORCID
53.96 11
31 Synthetic opioids have disrupted conventional wisdom for tre… (10.1016/j.dadr.2024.100268)
Abstract ORCID
53.96 11
32 Racial and ethnic data justice: The urgency of surveillance… (10.1016/j.dadr.2022.100082)
Abstract ORCID
52.07 10
33 Prevalence and predictors of medication for opioid use disor… (10.1016/j.dadr.2024.100239)
Abstract ORCID
52.07 10
34 “Smoking weed it gets you over the hump”: Cannabis co-use as… (10.1016/j.dadr.2024.100257)
Abstract ORCID
50.00 9
35 Perceptions, barriers, and facilitators of cannabis screenin… (10.1016/j.dadr.2024.100274)
Abstract ORCID
50.00 9
36 Alcohol use disorder treatment and outcomes among hospitaliz… (10.1016/j.dadr.2021.100004)
Abstract ORCID
47.71 8
37 Impact of an overdose reversal program in the context of a s… (10.1016/j.dadr.2021.100021)
Abstract ORCID
47.71 8
38 Cannabis use among adolescents and young adults during the C… (10.1016/j.dadr.2024.100232)
Abstract ORCID
47.71 8
39 A review of the landscape of state Tobacco 21 laws: Key comp… (10.1016/j.dadr.2024.100236)
Abstract ORCID
47.71 8
40 Association of economic and racial segregation with restrict… (10.1016/j.dadr.2024.100255)
Abstract ORCID
47.71 8
41 Perceptions of structural and provider-based substance use s… (10.1016/j.dadr.2024.100259)
Abstract ORCID
47.71 8
42 Attentional bias in tobacco use disorder using eye tracking:… (10.1016/j.dadr.2024.100294)
Abstract ORCID
47.71 8
43 Stigmatization of people with addiction by health profession… (10.1016/j.dadr.2023.100196)
Abstract
46.88 74
44 Towards a framework for implementing physician education in… (10.1016/j.dadr.2021.100001)
Abstract ORCID
45.15 7
45 Trends and correlates of abscess history among people who in… (10.1016/j.dadr.2023.100176)
Abstract ORCID
45.15 7
46 Reduced emergency department use among insured individuals r… (10.1016/j.dadr.2024.100233)
Abstract ORCID
45.15 7
47 Estimating changes in overdose death rates from increasing m… (10.1016/j.dadr.2024.100238)
Abstract ORCID
45.15 7
48 Tianeptine-involved emergency department visits, fatal overd… (10.1016/j.dadr.2024.100272)
Abstract ORCID
45.15 7
49 Prenatal cannabis exposure in the clinic and laboratory: Wha… (10.1016/j.dadr.2024.100282)
Abstract ORCID
45.15 7
50 Perspectives of people in Philadelphia who use fentanyl/hero… (10.1016/j.dadr.2022.100074)
Abstract
44.45 59